Cargando…

Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization

BACKGROUND: Optimizing treatment through microarray-based molecular subtyping is a promising method to address the problem of heterogeneity in breast cancer; however, current application is restricted to prediction of distant recurrence risk. This study investigated whether breast cancer molecular s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kao, Kuo-Jang, Chang, Kai-Ming, Hsu, Hui-Chi, Huang, Andrew T
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094326/ https://www.ncbi.nlm.nih.gov/pubmed/21501481 http://dx.doi.org/10.1186/1471-2407-11-143

Ejemplares similares

Dynamic Contrast Enhanced MRI and Intravoxel Incoherent Motion to Identify Molecular Subtypes of Breast Cancer with Different Vascular Normalization Gene Expression
por: Tsai, Wan-Chen, et al.
Publicado: (2021)

Molecular subtyping of breast cancer intrinsic taxonomy with oligonucleotide microarray and NanoString nCounter
por: Chen, Yen-Jen, et al.
Publicado: (2021)

Multimodal ultrasound features of breast cancers: correlation with molecular subtypes
por: Zhu, Jun-Yan, et al.
Publicado: (2023)

Expression of CDK7 correlates with molecular subtypes and predicts clinical outcomes in breast cancer
por: Tang, Lin, et al.
Publicado: (2021)

Overexpression of CARM1 in breast cancer is correlated with poorly characterized clinicopathologic parameters and molecular subtypes
por: Cheng, Hongxia, et al.
Publicado: (2013)

Optimal Selection of Imaging Examination for Lymph Node Detection of Breast Cancer With Different Molecular Subtypes
por: Zheng, Mingjie, et al.
Publicado: (2022)

BluePrint breast cancer molecular subtyping recognizes single and dual subtype tumors with implications for therapeutic guidance
por: Kuilman, Midas M., et al.
Publicado: (2022)

Molecular Subtypes of Uterine Leiomyosarcoma and Correlation with Clinical Outcome()()
por: Barlin, Joyce N., et al.
Publicado: (2015)

Discrepancy of Breast and Axillary Pathologic Complete Response and Outcomes in Different Subtypes of Node-positive Breast Cancer after Neoadjuvant Chemotherapy
por: Chen, Shin-Cheh, et al.
Publicado: (2021)

Clinical implications of intrinsic molecular subtypes of breast cancer for sentinel node status
por: Rossing, Maria, et al.
Publicado: (2021)

Serum CA125 is a predictive marker for breast cancer outcomes and correlates with molecular subtypes
por: Fang, Cheng, et al.
Publicado: (2017)

Correlation between the molecular subtype of breast cancer and the in vitro adenosine triphosphate-based chemosensitivity assay
por: Chang, Jina, et al.
Publicado: (2013)

Correlation analysis between molecular subtypes and Nottingham Prognostic Index in breast cancer
por: Zhen, Hongchao, et al.
Publicado: (2017)

Correlation between the CEM imaging characteristics and different molecular subtypes of breast cancer
por: Li, Na, et al.
Publicado: (2023)

Prognostic Implications of Molecular Subtypes in Primary Small Cell Lung Cancer and Their Correlation With Cancer Immunity
por: Qi, Jing, et al.
Publicado: (2022)

Radiologic-pathologic correlation in breast cancer: do MRI biomarkers correlate with pathologic features and molecular subtypes?
por: Galati, Francesca, et al.
Publicado: (2022)

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
por: Lehmann, Brian D., et al.
Publicado: (2016)

Claudin Expression in High Grade Invasive Ductal Carcinoma of the Breast: Correlation with the Molecular Subtype
por: Lu, Shaolei, et al.
Publicado: (2012)

PET-CT upstaging of unilateral operable breast cancer and its correlation with molecular subtypes
por: Singh, Srishti, et al.
Publicado: (2020)

Using microarray‐based subtyping methods for breast cancer in the era of high‐throughput RNA sequencing
por: Pedersen, Christina Bligaard, et al.
Publicado: (2018)

Metaplastic breast cancer: Treatment and prognosis by molecular subtype
por: Hu, Jin, et al.
Publicado: (2021)

Identification of molecular apocrine breast tumours by microarray analysis
por: Farmer, P, et al.
Publicado: (2005)

Prognostic correlations with the microbiome of breast cancer subtypes
por: Banerjee, Sagarika, et al.
Publicado: (2021)

Implications of differences in expression of sarcosine metabolism-related proteins according to the molecular subtype of breast cancer
por: Yoon, Ja Kyung, et al.
Publicado: (2014)

The molecular portraits of breast tumors are conserved across microarray platforms
por: Hu, Zhiyuan, et al.
Publicado: (2006)

Correlation of tumor uptake on breast-specific gamma imaging and fluorodeoxyglucose PET/CT with molecular subtypes of breast cancer
por: Lee, Soo Jin, et al.
Publicado: (2018)

Survival outcomes in elderly Taiwanese women according to breast cancer subtype and lymph node status: A single-center retrospective study
por: Lin, Kung-Hung, et al.
Publicado: (2021)

Identifying molecular subtypes in human colon cancer using gene expression and DNA methylation microarray data
por: REN, ZHONGLU, et al.
Publicado: (2015)

Expression of the Androgen Receptor and its Correlation with Molecular Subtypes in 980 Chinese Breast Cancer Patients
por: Qi, Ji-ping, et al.
Publicado: (2011)

Clinical and microarray analysis of breast cancers of all subtypes from two prospective preoperative chemotherapy studies
por: Okuma, H S, et al.
Publicado: (2016)

Molecular subtypes and precision treatment of triple-negative breast cancer
por: Zhao, Shen, et al.
Publicado: (2020)

Evaluating reproducibility of differential expression discoveries in microarray studies by considering correlated molecular changes
por: Zhang, Min, et al.
Publicado: (2009)

Immunogenic Cell Death-Relevant Damage-Associated Molecular Patterns and Sensing Receptors in Triple-Negative Breast Cancer Molecular Subtypes and Implications for Immunotherapy
por: Xu, Ming, et al.
Publicado: (2022)

An integrative deep learning framework for classifying molecular subtypes of breast cancer
por: Mohaiminul Islam, Md., et al.
Publicado: (2020)

Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer
por: Fan, Ming, et al.
Publicado: (2017)

Assessing the Correlation of Rate of Pathological Complete Response and Outcome in Post Neoadjuvant Chemotherapy Setting and Molecular Subtypes of Breast Cancer
por: Omair, Ahmad, et al.
Publicado: (2023)

RUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse mammary gland
por: McDonald, Laura, et al.
Publicado: (2014)

Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications
por: Kimbung, Siker, et al.
Publicado: (2015)

Correlation of BMI with breast cancer subtype and tumour size
por: Govind Babu, K, et al.
Publicado: (2018)

Genomic Correlates of DNA Damage in Breast Cancer Subtypes
por: Cabañas Morafraile, Esther, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1ggsu6mp8gj2sp8skp56jeqs7o